New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

DSHEA, Recent Nutraceutical Regulatory Updates and the Benefits of Third-Party Literature Discussed at NNFA Midwest Seminar

(Chicago, IL) April 8, 2002 -- Rakesh Amin, a partner at the law firm of Weaver & Amin, presented DSHEA: Recent Nutraceutical Regulatory Updates and the Benefits of Third-Party Literature at the NNFA-Midwest Seminar on April 19-21, 2002, at Louisville, KY.

Amin, a partner at the Chicago, IL-based law firm of Weaver & Amin and well-known expert in Food and Drug Administration (FDA) and Federal Trade Commission (FTC) state and federal regulatory and litigation issues, recently embarked on a series of seminar appearances in the U.S. and Europe to discuss dietary supplement industry issues.

Amin's presentation provided an overview of DSHEA and recent FDA/FTC regulatory developments, including the FDA’s recent Small Entity Compliance Guide on Dietary Supplement Structure/Function Claims. He focused on the marketing benefits that third-party literature provides and the legal ability to make therapeutic disease claims within third-party literature text in regards to the sale of dietary supplements. Amin also reviewed the legal requirements for the third-party literature exemption, types of acceptable publications and the consequences of non-compliance.

Weaver & Amin concentrates its practice in Food and Drug Administration, Federal Trade Commission, and related Federal and State regulatory compliance and litigation matters, contracts and business transactions, and intellectual property prosecution, maintenance, licensing, and litigation.

The firm's practice also includes the regulation of many consumer products such as cosmetics, medical devices, dietary supplements, food additives, organics, nutraceuticals, color additives, animal feeds, and biologics. A significant component of the practice involves new product labeling, clinical testing protocols, advertising, and legal and regulatory review of health claims and statements of nutritional support.

For information about DSHEA, regulatory updates and third-party literature, contact Weaver & Amin at (312) 701-0844 or visit the web site at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.